EUVIMED · CrossrefZeitschrift
Expert Opinion on Drug Discovery
ISSN 1746-0441 · Informa UK Limited
Neueste Artikel
Zebrafish phenotypic screening escapes the target trap: neurophenomics and the future of neuroactive drug discovery
Strategic optimization of physicochemical properties for enhanced brain exposure in preclinical drug discovery
AI-powered virtual cells, digital twins and agentic AI are reshaping multi-omics, spatial biology and drug discovery
Density functional theory and Bayesian optimization for therapeutic discovery
Harnessing industry-academia partnerships to advance X-ray crystallography in early drug discovery
Advances in phenotype-based drug discovery: lessons from radiation countermeasure research
Preclinical innovations and translational opportunities of non-opioid analgesics for Neuropathic pain: a narrative review
Breaking the rules by design: the evolution of Lipinski’s principles toward modern drug discovery
Recent progress in the application of fluorescence polarization assays to small molecule screening
Strategy-based design for the identification of next generation β-lactam antibiotics that evade resistance from Gram-negative pathogens
The rapid emergence of small molecule RNA modulator hit discovery: unlocking the potential
Design considerations for in silico drug discovery platform that can accelerate targeted drug repurposing: a focus on rare, neglected, and emerging diseases
Lymph node models of chronic lymphocytic leukemia for translational evaluation of new drug candidates
Using molecular modeling and QSAR-based design strategies for advancing the development of therapeutic solute carrier 6 (SLC6) transporter ligands
Organoids in drug discovery and development: emerging technologies to transition beyond animal models
Rethinking zebrafish anxiety models in drug discovery and precision psychiatry
From stochastic systems to governed intelligence: a neurosymbolic path for pharma
Current applications of isothermal titration calorimetry for lead optimization
Nano differential scanning fluorimetry in drug discovery: advances, applications, and limitations
Stagnation and selectivity in medicinal chemistry: synthetic reaction trends and their impact on molecular diversity
Crystallographic fragment screening in cancer and antiviral drug discovery: from electron density to translational outcomes
Cholinergic-targeted molecular hybrids: a renewed strategy for Alzheimer’s disease?
Preclinical discovery and clinical development of glofitamab in relapsed/ refractory large B-cell lymphomas
Balancing optimism versus potential risks of AI-driven drug discovery
Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology
Radiolysis in drug discovery: molecular modification, repurposing, and mechanistic insights
From mitochondrial signal to discovery decision: a reserve–demand framework for translational risk assessment
Why next-generation mechanistic models will transform drug discovery: integrating efficacy and safety
Targeting ferroptosis in lung cancer: emerging strategies and drug discovery opportunities
High-throughput screening assays for novel antibacterial identification: current advances and future prospects
EUVIMED